Search Hotels in Sausalito

San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of...

Topics Artificial Intelligence Economy

AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs

Today 14:00 EDT

Retail Investors Now Expect Viking Therapeutics To Bag A Deal After Novo Nordisk, Pfizer Engage In A Bidding War For Rival Metsera

Topics Artificial Intelligence Supply Chain

October 30, 2025

Via Stocktwits

Novo Nordisk Submits Revised Bid For Metsera, Enters A Bidding War With Pfizer

October 30, 2025

Via Stocktwits

AI Revolutionizes Pharma Supply Chains: A New Era of Localized Resilience and Efficiency

Today 13:57 EDT

The pharmaceutical industry is experiencing a profound and immediate transformation as Artificial Intelligence (AI) becomes a strategic imperative for localizing supply chains, fundamentally enhancing...

AI Revolutionizes Pharma R&D: A New Era of Accelerated Drug Discovery and Personalized Medicine

Topics Artificial Intelligence Economy Fraud

Today 13:51 EDT

Artificial intelligence (AI) is ushering in a transformative era for pharmaceutical research and development (R&D), fundamentally reshaping how new medicines are discovered, developed, and brought to...

The pharmaceutical industry is in the midst of a profound and rapid transformation, driven by the pervasive integration of Artificial Intelligence (AI). What was once a futuristic concept is, by late...

Topics Artificial Intelligence Intellectual Property

AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future

Today 13:28 EDT

Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 3.2% in the afternoon session after it reported strong third-quarter financial results that surpassed expectations and...

Topics Animal Testing Artificial Intelligence Economy

Why iRhythm (IRTC) Stock Is Trading Up Today

Today 13:01 EDT

AbbVie stock dipped early Friday, though the drug giant easily beat views.

Topics Artificial Intelligence World Trade

AbbVie Beats Third-Quarter Forecasts As Immunology Kingpin Grows 47%

Today 8:22 EDT

Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise

Today 2:52 EDT

Traders on Stocktwits linked Novo Nordisk’s renewed bid for Metsera to competition from Viking’s obesity drug VK2735, fueling further optimism.

Via Stocktwits

1 Safe-and-Steady Stock with Competitive Advantages and 2 We Turn Down

Today 0:43 EDT

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Edwards Lifesciences stock jumped late Thursday after the medtech company boosted its 2025 outlook after beating quarterly calls.

Edwards Lifesciences Pops As Third-Quarter Beat Lifts 2025 Guidance

October 30, 2025

Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain

October 30, 2025

As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush.

Via Benzinga

Topics ETFs

Thursday's session: most active stock in the S&P500 index

October 30, 2025

Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Thursday and uncover the stocks that are leading the way in terms of trading volume and market...

Via Chartmill

Check out the stocks that are attracting the most attention and driving market activity.

October 30, 2025

Let's dive into the action on the US markets on Thursday. Here are the most active stocks that are driving the market today.

Via Chartmill

Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera

October 30, 2025

Novo Nordisk kicked off a battle with Pfizer on Thursday, making an unsolicited $6.5 billion bid for obesity-focused Metsera.

Novo Nordisk's $9 billion offer for Metsera challenges Pfizer's existing merger deal, prompting sharp criticism and potential legal action.

Topics Economy Government

Pfizer Blasts Novo Nordisk's $9 Billion Counteroffer For Metsera As 'Reckless'

October 30, 2025

Via Benzinga

Alnylam Stock Has Already Doubled In 2025. Why It Could Rocket Again On Earnings.

October 30, 2025

The company easily beat third-quarter expectations and issued guidance that widely topped forecasts.

Investing in high-quality stocks with generous dividend payouts can help you gradually build substantial wealth.

Pfizer Addresses Proposal for Metsera

October 30, 2025

From Pfizer Inc.

Via Business Wire

Prediction: Putting $1,000 Into These Dividend Stocks Could Pay Off for Years

October 30, 2025

Income investors can capture yields above 5% from companies executing business transformations.

2 High-Yield Stocks With Fresh Catalysts

October 29, 2025

On October 29, 2025, the broader market exhibited a decidedly mixed performance, reflecting a prevailing sense of uncertainty among investors. Against this backdrop of fluctuating sentiment, the S&P...

Topics Lawsuit

S&P 500 Healthcare Sector Navigates Mixed Market Waters on October 29, 2025

October 29, 2025

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

'I Still Can't Believe It's Around': Cramer Rips Plug Power

October 29, 2025

Mad Money Lightning Round: Jim Cramer says Sempra (SRE) is a buy, supported by Wells Fargo's Overweight rating. Pfizer (PFE) and Dow (DOW) discussed. Plug Power (PLUG) faces concerns over shareholder...

Via Benzinga

Topics Stocks

1 S&P 500 Stock to Target This Week and 2 We Brush Off

October 29, 2025

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,...

Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for pregnant women.

Topics Stocks

Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety

October 28, 2025

Via Benzinga

Topics Lawsuit

Why NeoGenomics (NEO) Stock Is Trading Up Today

October 28, 2025

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 1.1% in the morning session after it reported third-quarter 2025 results where revenue beat Wall Street's expectations.

Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers

Topics World Trade

October 27, 2025

As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

3 Dividend-Paying Drug Stocks to Buy at a Discount

October 27, 2025

Some of the largest drugmakers in the world are trading at attractive valuations. Are they worth buying?

This pharma giant is entering the rapidly expanding market for weight loss drugs.

Topics Intellectual Property

What Is 1 of the Best Pharmaceutical Stocks to Buy Now?

October 27, 2025

The pharma giant is slated to report its latest quarterly numbers next week.

Should You Buy Pfizer Stock Before Nov. 4?

October 27, 2025